IVIVC IN DEVELOPMENT OF ORALLY INHALED PRODUCTS

Implementing IVIVC in development of orally inhaled products (Vit Perlik)

  • Understanding the requirements of OIP guideline and regulatory updates
  • Systemic exposure versus pulmonary deposition - use of truncated AUCs
  • Practical solutions to establish IVIVC for inhalation products
  • Flow dependency and next steps